Clinical Trials Browser

Phase 2 × belapectin × Dermatologic × Clear all

NCT04987996 2023-06-06

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Phase 2 Withdrawn

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Melanoma